ABBOTT LABORATORIES — Director's Dealing 2012

Jul 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-07-23

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-23	Common shares without par value	M	30000	$44.16	Acquired	432443	Direct
2012-07-23	Common shares without par value	F	24357	$65.06	Disposed	408086	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-23	Option (right to buy)	$44.16	M	30000	Disposed	2016-02-16	Common shares (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1037	Indirect
Common shares without par value	15000	Indirect
Common shares without par value	1941	Indirect
Common shares without par value	1941	Indirect
Common shares without par value	1941	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 23, 2012.

F2: Held in the Annette Newton-Freyman 1994 Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.

F3: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F4: These shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities.

F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.